Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017 (2017), Article ID 5608287, 12 pages
https://doi.org/10.1155/2017/5608287
Research Article

Association of the Composite Inflammatory Biomarker GlycA, with Exercise-Induced Changes in Body Habitus in Men and Women with Prediabetes

1Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, NC, USA
2Division of Medical Oncology, Department of Medicine, Duke University, Durham, NC, USA
3LipoScience, Laboratory Corporation of America Holdings, Morrisville, NC, USA
4Physical Medicine and Rehabilitation Service, Veterans Affairs Medical Center, Durham, NC, USA
5Division of Cardiology Medicine, Duke University Medical Center, Durham, NC, USA

Correspondence should be addressed to David B. Bartlett

Received 23 February 2017; Revised 11 April 2017; Accepted 24 April 2017; Published 31 May 2017

Academic Editor: Patricia C. Brum

Copyright © 2017 David B. Bartlett et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. C. Knowler, E. Barrett-Connor, S. E. Fowler et al., “Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin,” The New England Journal of Medicine, vol. 346, no. 6, pp. 393–403, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Li, P. Zhang, J. Wang et al., “The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study,” Lancet, vol. 371, no. 9626, pp. 1783–1789, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Tuomilehto, “Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance,” The New England Journal of Medicine, vol. 344, no. 18, pp. 1343–1350, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. X. R. Pan, G. W. Li, Y. H. Hu et al., “Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study,” Diabetes Care, vol. 20, no. 4, pp. 537–544, 1997. View at Publisher · View at Google Scholar
  5. W. E. Kraus, J. A. Houmard, B. D. Duscha et al., “Effects of the amount and intensity of exercise on plasma lipoproteins,” The New England Journal of Medicine, vol. 347, no. 19, pp. 1483–1492, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. J. L. Johnson, C. A. Slentz, J. A. Houmard et al., “Exercise training amount and intensity effects on metabolic syndrome (from studies of a targeted risk reduction intervention through defined exercise),” The American Journal of Cardiology, vol. 100, no. 12, pp. 1759–1766, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. L. A. Bateman, C. A. Slentz, L. H. Willis et al., “Comparison of aerobic versus resistance exercise training effects on metabolic syndrome (from the Studies of a Targeted Risk Reduction Intervention Through Defined Exercise - STRRIDE-AT/RT),” The American Journal of Cardiology, vol. 108, no. 6, pp. 838–844, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. K. M. Huffman, C. A. Slentz, L. A. Bateman et al., “Exercise-induced changes in metabolic intermediates, hormones, and inflammatory markers associated with improvements in insulin sensitivity,” Diabetes Care, vol. 34, no. 1, pp. 174–176, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. C. A. Slentz, L. A. Bateman, L. H. Willis et al., “Effects of exercise training alone vs a combined exercise and nutritional lifestyle intervention on glucose homeostasis in prediabetic individuals: a randomised trial,” Diabetiologia, vol. 59, no. 10, pp. 2088–2098, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Gleeson, N. C. Bishop, D. J. Stensel, M. R. Lindley, S. S. Mastana, and M. A. Nimmo, “The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease,” Nature Reviews. Immunology, vol. 11, no. 9, pp. 607–615, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. N. P. Walsh, M. Gleeson, R. J. Shephard et al., “Position statement. Part one: Immune function and exercise,” Exercise Immunology Review, vol. 17, no. 17, pp. 6–63, 2011. View at Google Scholar
  12. M. Cesari, B. W. Penninx, A. B. Newman et al., “Inflammatory markers and onset of cardiovascular events: results from the Health ABC study,” Circulation, vol. 108, no. 19, pp. 2317–2322, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. C. J. Hammett, H. C. Oxenham, J. C. Baldi et al., “Effect of six months’ exercise training on C-reactive protein levels in healthy elderly subjects,” Journal of the American College of Cardiology, vol. 44, no. 12, pp. 2411–2413, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. I. Tzoulaki, G. D. Murray, A. J. Lee, A. Rumley, G. D. Lowe, and F. G. Fowkes, “C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study,” Circulation, vol. 112, no. 7, pp. 976–983, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Nishimoto, “Cytokine signal regulation and autoimmune disorders,” Autoimmunity, vol. 38, no. 5, pp. 359–367, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. K. M. Huffman, G. P. Samsa, C. A. Slentz et al., “Response of high-sensitivity C-reactive protein to exercise training in an at-risk population,” American Heart Journal, vol. 152, no. 4, pp. 793–800, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Ahmad, M. Fiuzat, D. B. Mark et al., “The effects of exercise on cardiovascular biomarkers in patients with chronic heart failure,” American Heart Journal, vol. 167, no. 2, pp. 193–202, 2014, e1. View at Publisher · View at Google Scholar · View at Scopus
  18. B. J. Nicklas, F. C. Hsu, T. J. Brinkley et al., “Exercise training and plasma C-reactive protein and interleukin-6 in elderly people,” Journal of the American Geriatrics Society, vol. 56, no. 11, pp. 2045–2052, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. J. D. Bell, J. C. Brown, J. K. Nicholson, and P. J. Sadler, “Assignment of resonances for ‘acute-phase’ glycoproteins in high resolution proton NMR spectra of human blood plasma,” FEBS Letters, vol. 215, no. 2, pp. 311–315, 1987. View at Publisher · View at Google Scholar · View at Scopus
  20. J. D. Otvos, I. Shalaurova, J. Wolak-Dinsmore et al., “GlycA: a composite nuclear magnetic resonance biomarker of systemic inflammation,” Clinical Chemistry, vol. 61, no. 5, pp. 714–723, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Dungan, P. Binkley, and K. Osei, “GlycA is a novel marker of inflammation among non-critically ill hospitalized patients with type 2 diabetes,” Inflammation, vol. 38, no. 3, pp. 1357–1363, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. M. A. Connelly, C. Shimizu, D. A. Winegar et al., “Differences in GlycA and lipoprotein particle parameters may help distinguish acute Kawasaki disease from other febrile illnesses in children,” BMC Pediatrics, vol. 16, no. 1, p. 151, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. R. P. Dullaart, E. G. Gruppen, M. A. Connelly, J. D. Otvos, and J. D. Lefrandt, “GlycA, a biomarker of inflammatory glycoproteins, is more closely related to the leptin/adiponectin ratio than to glucose tolerance status,” Clinical Biochemistry, vol. 48, no. 12, pp. 811–814, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Lorenzo, A. Festa, A. J. Hanley, M. J. Rewers, A. Escalante, and S. M. Haffner, “Novel protein glycan-derived markers of systemic inflammation and C-reactive protein in relation to glycemia, insulin resistance, and insulin secretion,” Diabetes Care, vol. 40, no. 3, pp. 375–382, 2017. View at Publisher · View at Google Scholar
  25. M. A. Connelly, E. G. Gruppen, J. D. Otvos, and R. P. Dullaart, “Inflammatory glycoproteins in cardiometabolic disorders, autoimmune diseases and cancer,” Clinica Chimica Acta, vol. 459, pp. 177–186, 2016. View at Publisher · View at Google Scholar · View at Scopus
  26. R. W. McGarrah, J. P. Kelly, D. M. Craig et al., “A novel protein glycan-derived inflammation biomarker independently predicts cardiovascular disease and modifies the association of HDL subclasses with mortality,” Clinical Chemistry, vol. 63, no. 1, pp. 288–296, 2017. View at Publisher · View at Google Scholar
  27. A. O. Akinkuolie, J. E. Buring, P. M. Ridker, and S. Mora, “A novel protein glycan biomarker and future cardiovascular disease events,” Journal of the American Heart Association, vol. 3, no. 5, article e001221, 2014. View at Publisher · View at Google Scholar
  28. E. G. Gruppen, I. J. Riphagen, M. A. Connelly, J. D. Otvos, S. J. Bakker, and R. P. Dullaart, “GlycA, a pro-inflammatory glycoprotein biomarker, and incident cardiovascular disease: relationship with C-reactive protein and renal function,” PloS One, vol. 10, no. 9, article e0139057, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. D. A. Duprez, J. Otvos, O. A. Sanchez, R. H. Mackey, R. Tracy, and D. R. Jacobs Jr, “Comparison of the predictive value of GlycA and other biomarkers of inflammation for total death, incident cardiovascular events, noncardiovascular and noncancer inflammatory-related events, and total cancer events,” Clinical Chemistry, vol. 62, no. 7, pp. 1020–1031, 2016. View at Publisher · View at Google Scholar · View at Scopus
  30. A. O. Akinkuolie, R. J. Glynn, L. Padmanabhan, P. M. Ridker, and S. Mora, “Circulating N-linked glycoprotein side-chain biomarker, rosuvastatin therapy, and incident cardiovascular disease: an analysis from the JUPITER trial,” Journal of the American Heart Association, vol. 5, no. 7, article e003822, 2016. View at Publisher · View at Google Scholar
  31. A. O. Akinkuolie, A. D. Pradhan, J. E. Buring, P. M. Ridker, and S. Mora, “Novel protein glycan side-chain biomarker and risk of incident type 2 diabetes mellitus,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 35, no. 6, pp. 1544–1550, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. M. A. Connelly, E. G. Gruppen, J. Wolak-Dinsmore et al., “GlycA, a marker of acute phase glycoproteins, and the risk of incident type 2 diabetes mellitus: PREVEND study,” Clinica Chimica Acta, vol. 452, pp. 10–17, 2016. View at Publisher · View at Google Scholar · View at Scopus
  33. M. J. Ormseth, C. P. Chung, A. M. Oeser et al., “Utility of a novel inflammatory marker, GlycA, for assessment of rheumatoid arthritis disease activity and coronary atherosclerosis,” Arthritis Research & Therapy, vol. 17, no. 1, p. 117, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. D. B. Bartlett, M. A. Connelly, H. AbouAssi et al., “A novel inflammatory biomarker, GlycA, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in BMI-matched controls,” Arthritis Research & Therapy, vol. 18, no. 1, p. 86, 2016. View at Publisher · View at Google Scholar · View at Scopus
  35. C. P. Chung, M. J. Ormseth, M. A. Connelly et al., “GlycA, a novel marker of inflammation, is elevated in systemic lupus erythematosus,” Lupus, vol. 25, no. 3, pp. 296–300, 2016. View at Publisher · View at Google Scholar · View at Scopus
  36. L. Durcan, D. A. Winegar, M. A. Connelly, J. D. Otvos, L. S. Magder, and M. Petri, “Longitudinal evaluation of lipoprotein variables in systemic lupus erythematosus reveals adverse changes with disease activity and prednisone and more favorable profiles with hydroxychloroquine therapy,” The Journal of Rheumatology, vol. 43, no. 4, pp. 745–750, 2016. View at Publisher · View at Google Scholar · View at Scopus
  37. A. A. Joshi, J. B. Lerman, T. M. Aberra et al., “GlycA is a novel biomarker of inflammation and subclinical cardiovascular disease in psoriasis,” Circulation Research, vol. 119, no. 11, pp. 1242–1253, 2016. View at Publisher · View at Google Scholar · View at Scopus
  38. E. T. Howley, “Type of activity: resistance, aerobic and leisure versus occupational physical activity,” Medicine and Science in Sports and Exercise, vol. 33, 6 Supplement, pp. S364–S369, 2001, discussion S419-20. View at Publisher · View at Google Scholar
  39. W. E. Kraus, C. E. Torgan, B. D. Duscha et al., “Studies of a targeted risk reduction intervention through defined exercise (STRRIDE),” Medicine and Science in Sports and Exercise, vol. 33, no. 10, pp. 1774–1784, 2001. View at Publisher · View at Google Scholar
  40. W. E. Siri, “Body composition from fluid spaces and density: analysis of methods. 1961,” Nutrition, vol. 9, no. 5, pp. 480–491, 1993, discussion 480, 492. View at Google Scholar
  41. S. R. Ginde, A. Geliebter, F. Rubiano et al., “Air displacement plethysmography: validation in overweight and obese subjects,” Obesity Research, vol. 13, no. 7, p. 1232, 2005. View at Publisher · View at Google Scholar
  42. P. Dempster and S. Aitkens, “A new air displacement method for the determination of human body composition,” Medicine and Science in Sports and Exercise, vol. 27, no. 12, pp. 1692–1697, 1995. View at Google Scholar
  43. B. A. Irving, J. Y. Weltman, D. W. Brock, C. K. Davis, G. A. Gaesser, and A. Weltman, “NIH ImageJ and Slice-O-Matic computed tomography imaging software to quantify soft tissue,” Obesity (Silver Spring), vol. 15, no. 2, pp. 370–376, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. K. J. Ellis, “Human body composition: in vivo methods,” Physiological Reviews, vol. 80, no. 2, pp. 649–680, 2000. View at Google Scholar
  45. E. J. Jeyarajah, W. C. Cromwell, and J. D. Otvos, “Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy,” Clinics in Laboratory Medicine, vol. 26, no. 4, pp. 847–870, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. F. Faul, E. Erdfelder, A. G. Lang, and A. Buchner, “G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences,” Behavior Research Methods, vol. 39, no. 2, pp. 175–191, 2007. View at Publisher · View at Google Scholar
  47. C. Gabay and I. Kushner, “Acute-phase proteins and other systemic responses to inflammation,” The New England Journal of Medicine, vol. 340, no. 6, pp. 448–454, 1999. View at Publisher · View at Google Scholar · View at Scopus
  48. O. Gornik and G. Lauc, “Glycosylation of serum proteins in inflammatory diseases,” Disease Markers, vol. 25, no. 4-5, pp. 267–278, 2008. View at Publisher · View at Google Scholar
  49. J. M. Kremer, J. Wilting, and L. H. Janssen, “Drug binding to human alpha-1-acid glycoprotein in health and disease,” Pharmacological Reviews, vol. 40, no. 1, pp. 1–47, 1988. View at Google Scholar
  50. J. N. Arnold, R. Saldova, U. M. Hamid, and P. M. Rudd, “Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation,” Proteomics, vol. 8, no. 16, pp. 3284–3293, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. K. Marino, J. Bones, J. J. Kattla, and P. M. Rudd, “A systematic approach to protein glycosylation analysis: a path through the maze,” Nature Chemical Biology, vol. 6, no. 10, pp. 713–723, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. O. Gornik, L. Royle, D. J. Harvey et al., “Changes of serum glycans during sepsis and acute pancreatitis,” Glycobiology, vol. 17, no. 12, pp. 1321–1332, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. K. Higai, Y. Azuma, Y. Aoki, and K. Matsumoto, “Altered glycosylation of α1-acid glycoprotein in patients with inflammation and diabetes mellitus,” Clinica Chimica Acta, vol. 329, no. 1-2, pp. 117–125, 2003. View at Publisher · View at Google Scholar · View at Scopus
  54. A. J. Bleasby, J. C. Knowles, and N. J. Cooke, “Microheterogeneity of α1-acid glycoprotein: lack of discrimination between benign and malignant inflammatory disease of the lung,” Clinica Chimica Acta, vol. 150, no. 3, pp. 231–235, 1985. View at Publisher · View at Google Scholar · View at Scopus
  55. K. Fischer, J. Kettunen, P. Würtz et al., “Biomarker profiling by nuclear magnetic resonance spectroscopy for the prediction of all-cause mortality: an observational study of 17,345 persons,” PLoS Medicine, vol. 11, no. 2, article e1001606, 2014. View at Publisher · View at Google Scholar · View at Scopus
  56. E. Prescott, R. Hjardem-Hansen, F. Dela, A. S. Teisner, and H. Nielsen, “Exercise training in older patients with systolic heart failure: adherence, exercise capacity, inflammation and glycemic control,” Scandinavian Cardiovascular Journal, vol. 43, no. 4, pp. 249–255, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. M. E. Lavoie, M. Faraj, I. Strychar et al., “Synergistic associations of physical activity and diet quality on cardiometabolic risk factors in overweight and obese postmenopausal women,” The British Journal of Nutrition, vol. 109, no. 4, pp. 605–614, 2013. View at Publisher · View at Google Scholar · View at Scopus
  58. F. M. Finucane, J. Luan, N. J. Wareham et al.D. B. Savage, “Correlation of the leptin:adiponectin ratio with measures of insulin resistance in non-diabetic individuals,” Diabetologia, vol. 52, no. 11, pp. 2345–2349, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. A. Gastaldelli, Y. Miyazaki, M. Pettiti et al., “Metabolic effects of visceral fat accumulation in type 2 diabetes,” The Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 11, pp. 5098–5103, 2002. View at Publisher · View at Google Scholar · View at Scopus
  60. H. Tilg and A. R. Moschen, “Adipocytokines: mediators linking adipose tissue, inflammation and immunity,” Nature Reviews. Immunology, vol. 6, no. 10, pp. 772–783, 2006. View at Publisher · View at Google Scholar · View at Scopus
  61. P. D. Chandler, A. O. Akinkuolie, D. K. Tobias et al., “Association of N-linked glycoprotein acetyls and colorectal cancer incidence and mortality,” PloS One, vol. 11, no. 11, article e0165615, 2016. View at Publisher · View at Google Scholar · View at Scopus
  62. B. D. Duscha, C. A. Slentz, J. L. Johnson et al., “Effects of exercise training amount and intensity on peak oxygen consumption in middle-age men and women at risk for cardiovascular disease,” Chest, vol. 128, no. 4, pp. 2788–2793, 2005. View at Publisher · View at Google Scholar · View at Scopus
  63. C. A. Slentz, L. B. Aiken, J. A. Houmard et al., “Inactivity, exercise, and visceral fat. STRRIDE: a randomized, controlled study of exercise intensity and amount,” Journal of Applied Physiology, vol. 99, no. 4, pp. 1613–1618, 2005. View at Publisher · View at Google Scholar · View at Scopus
  64. K. Karstoft, T. P. Solomon, M. J. Laye, and B. K. Pedersen, “Daily marathon running for a week—the biochemical and body compositional effects of participation,” Journal of Strength and Conditioning Research, vol. 27, no. 11, pp. 2927–2933, 2013. View at Publisher · View at Google Scholar · View at Scopus
  65. A. Boyum, P. Wiik, E. Gustavsson et al., “The effect of strenuous exercise, calorie deficiency and sleep deprivation on white blood cells, plasma immunoglobulins and cytokines,” Scandinavian Journal of Immunology, vol. 43, no. 2, pp. 228–235, 1996. View at Publisher · View at Google Scholar
  66. H. Liesen, B. Dufaux, and W. Hollmann, “Modifications of serum glycoproteins the days following a prolonged physical exercise and the influence of physical training,” European Journal of Applied Physiology and Occupational Physiology, vol. 37, no. 4, pp. 243–254, 1977. View at Publisher · View at Google Scholar · View at Scopus
  67. I. T. Gilmore, A. Burroughs, I. M. Murray-Lyon, R. Williams, D. Jenkins, and A. Hopkins, “Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London,” Gut, vol. 36, no. 3, pp. 437–441, 1995. View at Publisher · View at Google Scholar
  68. M. A. Banerji, M. C. Buckley, R. L. Chaiken, D. Gordon, H. E. Lebovitz, and J. G. Kral, “Liver fat, serum triglycerides and visceral adipose tissue in insulin-sensitive and insulin-resistant black men with NIDDM,” International Journal of Obesity and Related Metabolic Disorders, vol. 19, no. 12, pp. 846–850, 1995. View at Google Scholar
  69. T. Goto, T. Onuma, K. Takebe, and J. G. Kral, “The influence of fatty liver on insulin clearance and insulin resistance in non-diabetic Japanese subjects,” International Journal of Obesity and Related Metabolic Disorders, vol. 19, no. 12, pp. 841–845, 1995. View at Google Scholar
  70. S. Saadeh, Z. M. Younossi, E. M. Remer et al., “The utility of radiological imaging in nonalcoholic fatty liver disease,” Gastroenterology, vol. 123, no. 3, pp. 745–750, 2002. View at Publisher · View at Google Scholar · View at Scopus
  71. C. Ricci, R. Longo, E. Gioulis et al., “Noninvasive in vivo quantitative assessment of fat content in human liver,” Journal of Hepatology, vol. 27, no. 1, pp. 108–113, 1997. View at Publisher · View at Google Scholar · View at Scopus
  72. M. Kolak, J. Westerbacka, V. R. Velagapudi et al., “Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity,” Diabetes, vol. 56, no. 8, p. 1960, 2007. View at Publisher · View at Google Scholar · View at Scopus
  73. A. Seppala-Lindroos, S. Vehkavaara, A. M. Häkkinen et al., “Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men,” The Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 7, pp. 3023–3028, 2002. View at Publisher · View at Google Scholar
  74. E. Fabbrini and F. Magkos, “Hepatic steatosis as a marker of metabolic dysfunction,” Nutrients, vol. 7, no. 6, pp. 4995–5019, 2015. View at Publisher · View at Google Scholar · View at Scopus
  75. C. A. Slentz, L. A. Bateman, L. H. Willis et al., “Effects of aerobic vs. resistance training on visceral and liver fat stores, liver enzymes, and insulin resistance by HOMA in overweight adults from STRRIDE AT/RT,” American Journal of Physiology. Endocrinology and Metabolism, vol. 301, no. 5, pp. E1033–E1039, 2011. View at Publisher · View at Google Scholar · View at Scopus
  76. B. Vozarova, N. Stefan, R. S. Lindsay et al., “High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes,” Diabetes, vol. 51, no. 6, pp. 1889–1895, 2002. View at Publisher · View at Google Scholar
  77. L. E. Davidson, J. L. Kuk, T. S. Church, and R. Ross, “Protocol for measurement of liver fat by computed tomography,” Journal of Applied Physiology, vol. 100, no. 3, pp. 864–868, 2006. View at Publisher · View at Google Scholar · View at Scopus
  78. L. Kreel, “Computerised tomography and the liver,” Clinical Radiology, vol. 28, no. 6, pp. 571–581, 1977. View at Publisher · View at Google Scholar · View at Scopus
  79. J. T. Gonzalez, C. J. Fuchs, J. A. Betts, and L. J. van Loon, “Liver glycogen metabolism during and after prolonged endurance-type exercise,” American Journal of Physiology. Endocrinology and Metabolism, vol. 311, no. 3, pp. E543–E553, 2016. View at Publisher · View at Google Scholar · View at Scopus
  80. J. T. Gonzalez, C. J. Fuchs, F. E. Smith et al., “Ingestion of glucose or sucrose prevents liver but not muscle glycogen depletion during prolonged endurance-type exercise in trained cyclists,” American Journal of Physiology. Endocrinology and Metabolism, vol. 309, no. 12, pp. E1032–E1039, 2015. View at Publisher · View at Google Scholar · View at Scopus
  81. M. Macauley, F. E. Smith, P. E. Thelwall, K. G. Hollingsworth, and R. Taylor, “Diurnal variation in skeletal muscle and liver glycogen in humans with normal health and type 2 diabetes,” Clinical Science (London, England), vol. 128, no. 10, pp. 707–713, 2015. View at Publisher · View at Google Scholar · View at Scopus
  82. E. J. Stevenson, P. E. Thelwall, K. Thomas, F. Smith, J. Brand-Miller, and M. I. Trenell, “Dietary glycemic index influences lipid oxidation but not muscle or liver glycogen oxidation during exercise,” American Journal of Physiology. Endocrinology and Metabolism, vol. 296, no. 5, pp. E1140–E1147, 2009. View at Publisher · View at Google Scholar · View at Scopus